Psychedelic medicines in major depression: progress and future challenges (2021)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1007/978-981-33-6044-0_26
- Subjects: DEPRESSÃO; FARMACOTERAPIA; ALUCINOSES; PSIQUIATRIA
- Keywords: Psychedelics; Hallucinogens; Psilocybin; Ayahuasca; Mental health; Depression
- Language: Inglês
- Imprenta:
- Source:
- Título: Major depressive disorder: rethinking and understanding recent discoveries
- Volume/Número/Paginação/Ano: 563 p.
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BOUSO, Jose Carlos et al. Psychedelic medicines in major depression: progress and future challenges. Major depressive disorder: rethinking and understanding recent discoveries. Tradução . Singapore: Springer, 2021. p. 563 . Disponível em: https://doi.org/10.1007/978-981-33-6044-0_26. Acesso em: 30 dez. 2025. -
APA
Bouso, J. C., Ona, G., Santos, R. G. dos, & Hallak, J. E. C. (2021). Psychedelic medicines in major depression: progress and future challenges. In Major depressive disorder: rethinking and understanding recent discoveries (p. 563 ). Singapore: Springer. doi:10.1007/978-981-33-6044-0_26 -
NLM
Bouso JC, Ona G, Santos RG dos, Hallak JEC. Psychedelic medicines in major depression: progress and future challenges [Internet]. In: Major depressive disorder: rethinking and understanding recent discoveries. Singapore: Springer; 2021. p. 563 .[citado 2025 dez. 30 ] Available from: https://doi.org/10.1007/978-981-33-6044-0_26 -
Vancouver
Bouso JC, Ona G, Santos RG dos, Hallak JEC. Psychedelic medicines in major depression: progress and future challenges [Internet]. In: Major depressive disorder: rethinking and understanding recent discoveries. Singapore: Springer; 2021. p. 563 .[citado 2025 dez. 30 ] Available from: https://doi.org/10.1007/978-981-33-6044-0_26 - Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Psychedelics in psychiatry
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Natural hallucinogens in mental health [Editorial]
Informações sobre o DOI: 10.1007/978-981-33-6044-0_26 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003241770.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
